Are there genes associated with a lower ability to build muscle or weaker tendons and ligaments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Genetic Factors in Muscle Building and Connective Tissue Strength

Yes, specific genes have been identified that influence muscle-building capacity and tendon/ligament integrity, though the clinical utility of genetic testing for these traits remains limited due to lack of replication across populations.

Genes Associated with Reduced Muscle-Building Capacity

The ACTN3 p.R577X polymorphism (null allele) is the most replicated genetic variant associated with reduced power/strength performance. This variant causes a shift in fast-twitch muscle fiber properties toward slow-twitch characteristics, resulting in decreased metabolic enzyme activity in skeletal muscle and reduced capacity for explosive strength and power development 1. Individuals with the null allele are over-represented in endurance athletes compared to power athletes, suggesting this genetic variant fundamentally alters muscle fiber composition away from strength-building capacity 1.

Beyond ACTN3, the broader genetic architecture of muscle-building response shows considerable individual variability:

  • Resistance training response varies dramatically between individuals due to genetic factors, with twin and family studies demonstrating moderate heritability of training adaptations 1.
  • The Heritage Family Study documented extreme heterogeneity in training responses, with changes in VO2 max ranging from -114 to 1097 mL/min after standardized exercise programs 1.
  • Large individual variabilities in response to resistance training have been consistently reported, indicating genetic factors substantially influence muscle-building capacity 1.

Genes Associated with Weaker Tendons and Ligaments

Two specific genes have been identified with replicated associations to tendon and ligament injury susceptibility:

COL5A1 (Collagen V Alpha 1 Gene)

  • This gene encodes a component of type V collagen, which regulates collagen fiber assembly and fiber diameters 2.
  • Variants in COL5A1 have been associated with Achilles tendinopathies 2.
  • Type V collagen plays a critical structural role in determining the mechanical properties of connective tissues 2.

TNC (Tenascin C Gene)

  • Sequence variants of the TNC gene have been associated with both Achilles tendinopathies and Achilles tendon ruptures 2.
  • TNC regulates the tissue's response to mechanical load, making it functionally critical for tendon integrity under stress 2.
  • This gene encodes an important structural component that modulates how tendons handle physical demands 2.

Additional Genetic Factors in Connective Tissue

  • Genes encoding for collagen, matrix metallopeptidases, and growth factors have all been implicated in tendon and ligament injury susceptibility 3.
  • Studies suggest genetic components exist for rotator cuff and anterior cruciate ligament injuries, though specific genes have not yet been definitively identified 2.
  • Several single nucleotide polymorphisms (SNPs) have been associated with soft tissue ruptures, muscle strain, and stress fractures, though these lack current clinical utility due to limited replication 1.

Critical Limitations and Clinical Context

The current state of sport and exercise genomics reveals that most genetic findings lack sufficient replication to guide clinical decision-making:

  • Sport and exercise-related genes confirmed to influence athletic traits have not been definitively identified due to lack of replication in independent populations 1.
  • Genome-wide association studies (GWAS) of elite athletes have failed to identify genetic variants at genome-wide significance levels 1.
  • SNPs associated with musculoskeletal injuries have no current clinical utility because they have been replicated in limited independent populations 1.

Why the Evidence Remains Inconclusive

Two fundamental problems undermine genetic discovery in this field:

  1. Small sample sizes: Common SNPs show modest odds ratios of 1.1-1.5, requiring approximately 5,500 cases and controls to detect associations with adequate statistical power 1.

  2. Poor phenotyping: Athletic performance and injury susceptibility are complex traits regulated by networks of genes and pathways, yet most studies use ambiguous definitions like "elite athlete" without comprehensive physiological characterization 1.

Practical Implications

Tendon and ligament injuries do not have a single genetic cause, and environment and lifestyle play critical roles in combination with genetic profile 3. While predictive genomic profiling theoretically could identify genetic advantages and barriers, the multifactorial nature of these traits means genetic information alone cannot reliably predict individual outcomes 3.

Functional analysis of identified SNPs is needed to achieve greater understanding of mechanisms underlying musculoskeletal injury susceptibility 1. Until such mechanistic understanding is achieved and findings are replicated across diverse populations, genetic testing for muscle-building capacity or connective tissue strength lacks clinical utility for injury prevention or training optimization.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tendon and ligament injuries: the genetic component.

British journal of sports medicine, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.